Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi Capital/Financing Update 2018

Jun 13, 2018

1643_rns_2018-06-13_68731fcb-cc90-405f-b2da-4c74c2bd02b3.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

FWP 1 d561325dfwp.htm FWP FWP

Filed pursuant to Rule 433

Registration Statement No. 333-210203

June 12, 2018

Sanofi

Pricing Term Sheet for the 2028 Notes

U.S.$1,000,000,000 3.625% Notes due 2028 (the “2028 Notes”)

Issuer Sanofi
Format SEC-registered global notes
Title 3.625% Notes due 2028 (the “2028 Notes”)
Principal U.S.$1,000,000,000
Issue Price 99.270%
Pricing Date June 12, 2018
Expected Settlement Date June 19, 2018 (T+5)
Maturity Date June 19, 2028
Day Count 30/360
Day Count Convention Following unadjusted
Optional Redemption Make-whole call at Treasury Rate plus 15 bps before March 19, 2028 Par call at 100% principal amount on or after March 19, 2028
Tax Redemption Applicable
Ranking Unsecured and unsubordinated
Interest Rate 3.625% per annum
Benchmark Treasury 2.875% due May 15, 2028
Benchmark Treasury Price 99-08
Benchmark Treasury Yield 2.963%
Spread to Benchmark Treasury 75 bps
Yield to Maturity 3.713%
Date Interest Starts Accruing June 19, 2018
Interest Payment Dates Each June 19 and December 19, commencing December 19, 2018
Trustee Deutsche Bank Trust Company Americas
Listing None
Denominations U.S.$2,000 and increments of U.S.$1,000 above that amount
Expected Ratings of the Notes* Moody’s: A1/Stable Standard & Poor’s: AA/Stable Scope Ratings: AA/Stable
CUSIP/ISIN 801060AD6 / US801060AD60
Global Coordinators and Joint Book-Running Managers Barclays Capital Inc. Morgan Stanley &
Co. LLC
Joint Book-Running Managers Citigroup Global Markets Inc. Deutsche Bank
Securities Inc. MUFG Securities Americas Inc.
  • A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may obtain these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, copies may be obtained from Barclays Capital Inc. at 1-888-603-5847, Morgan Stanley & Co. LLC at 1-866-718-1649, Citigroup Global Markets Inc. at 1-800-831-9146, Deutsche Bank Securities Inc. at 1-800-503-4611 and MUFG Securities Americas Inc. at 1-877-649-6848.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.